ARCHIVES

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Two OAM Advisors Criticize Third over ACS Membership

July 23, 1993

NCI RFA: Basic Biobehavioral Research

August 6, 1999

Lasker Official Urges Congressional Support Of NCI Bypass Budget

April 20, 1990

Columbia Formally Names As 21st Comprehensive Center

March 9, 1979

BSA Eliminates Second Review For P01 Grants; R01Payline To increase to 24th Percentile

November 23, 1997

DCPC Board Votes To Keep Women’s Health Trial Alive, At Least For Now; Issue Goes To NCAB

September 25, 1987